These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1904902)

  • 1. Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis.
    Barral-Netto M; Barral A; Santos SB; Carvalho EM; Badaro R; Rocha H; Reed SG; Johnson WD
    J Immunol; 1991 Jul; 147(1):281-4. PubMed ID: 1904902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis.
    Carvalho EM; Bacellar O; Brownell C; Regis T; Coffman RL; Reed SG
    J Immunol; 1994 Jun; 152(12):5949-56. PubMed ID: 8207220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 enhances Th1-type responses in human Leishmania donovani infections.
    Ghalib HW; Whittle JA; Kubin M; Hashim FA; el-Hassan AM; Grabstein KH; Trinchieri G; Reed SG
    J Immunol; 1995 May; 154(9):4623-9. PubMed ID: 7722314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.
    Hailu A; van der Poll T; Berhe N; Kager PA
    Am J Trop Med Hyg; 2004 Nov; 71(5):561-7. PubMed ID: 15569785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
    Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
    Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in the number of UCHL-1+ cells and IL-2 production in the peripheral blood of patients with visceral leishmaniasis.
    Cillari E; Milano S; Dieli M; Maltese E; Di Rosa S; Mansueto S; Salerno A; Liew FY
    J Immunol; 1991 Feb; 146(3):1026-30. PubMed ID: 1824848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
    Elg SA; Hill RB; Heldman L; Ramakrishnan S
    Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of soluble interleukin-4 receptor in the sera of patients with visceral leishmaniasis.
    Sang DK; Ouma JH; John CC; Whalen CC; King CL; Mahmoud AA; Heinzel FP
    J Infect Dis; 1999 Mar; 179(3):743-6. PubMed ID: 9952391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients.
    Vitale G; Reina G; Mansueto S; Malta R; Gambino G; Mocciaro C; D'Agostino R; Dieli M; Cillari E
    Clin Exp Immunol; 1992 Nov; 90(2):219-22. PubMed ID: 1424277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation by interleukin 2 of interleukin 2 receptors and gamma-interferon synthesis by human thymocytes: augmentation of interleukin 2 receptors by interleukin 2.
    Reem GH; Yeh NH
    J Immunol; 1985 Feb; 134(2):953-8. PubMed ID: 2981271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2.
    Vilcek J; Henriksen-Destefano D; Siegel D; Klion A; Robb RJ; Le J
    J Immunol; 1985 Sep; 135(3):1851-6. PubMed ID: 3926889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of soluble IL-2 receptor and IL-4, and nonelevation of IFN-gamma in sera from patients with allergic asthma.
    Hashimoto S; Amemiya E; Tomita Y; Kobatashi T; Arai K; Yamaguchi M; Horie T
    Ann Allergy; 1993 Nov; 71(5):455-8. PubMed ID: 8250351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beryllium induces IL-2 and IFN-gamma in berylliosis.
    Tinkle SS; Kittle LA; Schumacher BA; Newman LS
    J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
    Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells.
    Kedar E; Rezai AR; Giorgi JV; Gale RP; Champlin RE; Mitsuyasu RT; Fahey JL
    Nat Immun Cell Growth Regul; 1988; 7(1):13-30. PubMed ID: 2896298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.
    Siegel JP; Djeu JY; Stocks NI; Masur H; Gelmann EP; Quinnan GV
    J Clin Invest; 1985 Jun; 75(6):1957-64. PubMed ID: 2989337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania donovani: role of CD2 on CD4+ T-cell function in Visceral Leishmaniasis.
    Bimal S; Singh SK; Sinha S; Pandey K; Sinha PK; Ranjan A; Bhattacharya SK; Das P
    Exp Parasitol; 2008 Feb; 118(2):238-46. PubMed ID: 17904553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The major circulating immunosuppressive activity in American visceral leishmaniasis patients is associated with a high-molecular weight fraction and is not mediated by IgG, IgG immune complexes or lipoproteins.
    Soares NM; Ferraz TP; Nascimento EG; Carvalho EM; Pontes-de-Carvalho L
    Microb Pathog; 2006 Jun; 40(6):254-60. PubMed ID: 16626930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes. Inhibition of IL-2 receptor expression.
    Beltz LA; Sztein MB; Kierszenbaum F
    J Immunol; 1988 Jul; 141(1):289-94. PubMed ID: 3132504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.